Stay updated on KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the Record History.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAdded revision entry v3.4.2 and removed v3.4.1 from the Record History page, updating the displayed site version history.SummaryDifference0.1%

- Check35 days agoChange DetectedAdded a new revision entry (v3.4.1) to the record history and removed a funding-status notice along with an older revision (v3.4.0). These are administrative updates to the page's history and do not affect the underlying study data or public-facing trial information.SummaryDifference0.8%

- Check42 days agoChange DetectedA site-wide notice about government funding and operating status was added at the top of the page, but the study record content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check49 days agoChange DetectedThe page now includes a glossary display option and color-coded highlights for additions and deletions, with a new revision label (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check57 days agoChange DetectedThe record history now lists a new revision entry v3.3.4 and removes v3.3.3 from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.